Document is current
Any future updates will be listed below
-
Authors
Qin, Kang
Gay, Carl M. https://orcid.org/0000-0002-4907-0718
Byers, Lauren A. https://orcid.org/0000-0002-0780-2677
Zhang, Jianjun https://orcid.org/0000-0001-7872-3477
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 25 April 2025
First Online: 5 June 2025
Competing interests
: C.M.G. serves on advisory committees for Abdera, AstraZeneca, BMS, Daiichi Sankyo, G1, Jazz, MonteRosa, Roche/Genentech and reports Speaking Engagement from AstraZeneca, BeiGene, MJH, OncLive, PeerView, Targeted Healthcare, and receives Paid Consulting from Catalyst, Kisoji, STCube. L.A.B. serves on advisory committees for AstraZeneca, AbbVie, Genetech, Amgen, Daiichi Sankyo, Novartis and has research support from AstraZeneca, Amgen. J.Z. reports grants from Merck and Helius, grants and personal fees from Johnson and Johnson and Novartis, personal fees from Bristol-Myers Squibb, AstraZeneca, GenePlus, Innovent, Varian, Catalyst and Hengrui outside the submitted work. K.G. declares no competing interests.
